[Pharmaceutical care for older adults. Application of STOPP-START criteria].
Atención farmacéutica de adultos mayores. Aplicación de los criterios STOPP-START.
Adulto mayor
Aged
Atención farmacéutica
Farmacoepidemiología
Inappropriate prescribing/prevention &control
Medication use
Patient safety
Pharmaceutical care
Pharmacoepidemiology
Prescripción inadecuada/prevención y control
Seguridad del paciente
Uso de medicamentos
Journal
Journal of healthcare quality research
ISSN: 2603-6479
Titre abrégé: J Healthc Qual Res
Pays: Spain
ID NLM: 101735273
Informations de publication
Date de publication:
Historique:
received:
16
05
2019
revised:
22
08
2019
accepted:
23
08
2019
pubmed:
25
12
2019
medline:
2
7
2021
entrez:
25
12
2019
Statut:
ppublish
Résumé
Drug-related problems can be caused by potentially inappropriate prescribing (PIP), one of the most used tools for its identification are the STOPP (Older Persons' potentially inappropriate Prescriptions) - START (Screening Tool to Alert doctors to Right Treatment) criteria. The objective of this study is to determine PIP in older adults who receive pharmaceutical care in the Pharmacotherapy Optimization Unit (POU)-Rosario. Pharmacoepidemiological observational study, which evaluates the quality of medication use. Workplace: POU-Rosario. Population under study: adults over 60 years of age, who received pharmacotherapy follow-up during the period March 2017 to February 2018. PIPs were identified using the STOPP-START criteria, 2014 version; selecting the most appropriate criteria to assess outpatient pharmacotherapy. Prevalence of PIP and amount of PIP per active principle were estimated. 50 patients older than 60 years received pharmacotherapy follow-up in the POU; 47 patients (94.0%) had at least one PIP corresponding to a STOPP criterion; 17 STOPP criteria were found among the 41 initially selected, leading to 145 PIPs identified. And 7 START criteria among the 11 initially selected, leading to 50 PIPs identified. Medications with a higher amount of PIPs: benzodiazepines and proton pump inhibitors. This study allowed the identification of a high prevalence of PIP. The data obtained show the usefulness of these criteria. The STOPP-START criteria have been included to support decision making during pharmacotherapy follow-up to propose pharmaceutical interventions, in order to enhance pharmacotherapy. These activities contribute to patient safety, a dimension of health quality.
Identifiants
pubmed: 31870864
pii: S2603-6479(19)30116-2
doi: 10.1016/j.jhqr.2019.08.003
pii:
doi:
Types de publication
Journal Article
Observational Study
Langues
spa
Sous-ensembles de citation
IM
Pagination
35-41Informations de copyright
Copyright © 2019 FECA. Publicado por Elsevier España, S.L.U. All rights reserved.